According to the latest forecast, the digital inhaler market for asthma and COPD will reach $3.56 billion. Although connecting inhalers is a product of emerging markets, in recent years pharmaceutical giants AstraZeneca and Novartis, major equipment companies such as Philips and Respironics, and small companies such as Propeller Health have made heavy investments in this area. Rapid growth momentum. The authors say that this momentum will continue in the next few years, with population aging and the surge in the prevalence of chronic respiratory diseases being the two drivers. They also predict that markets outside North America will grow rapidly. The company predicts that the Asia-Pacific compound annual growth rate (CAGR) will reach 17% between now and 2024. Due to the impact of economic development in emerging countries, national income growth in countries such as China, India, and Brazil will affect the demand for advanced respiratory equipment. At the same time, the technology that caters to children and the elderly will make the device very popular, improve patient compliance, medication tracking and real-time health data tracking to improve patient-doctoral connections, which will significantly drive the market for the next nine years. increase. According to Grand View data, the US metered-dose inhaler market in 2015 was $563.9 million, which is the largest market segment in the digital inhalation market. However, they predict that the dry powder inhalation market will catch up and the CAGR will reach 16.9%. In addition, the market value of brand equipment this year is $747.6 million. The report also pointed out several companies in this field, including Teva Pharmaceuticals, which entered the field of inhalers after acquiring Gecko Medical ; Opko Medical acquired Inspiro Medical, which is also the mainstay of Australian smart inhaler company Adherium. Investors; Propeller Medical manufactures inhalation sensors, and its partners are gradually increasing, with GlaxoSmithKline and Boehringer Ingelheim collaborating with them. At the same time, the report also pointed out that Philips Breath, Novartis and Grandark Grand Mark also began to enter this field. Granmark introduced smart inhaler products to track the remaining amount of drugs, and issued a reminder when the balance was insufficient. Novartis announced in January this year that it has partnered with Qualcomm Life to develop a connectable COPD inhaler.
We're Professional Supplier Extract Powder manufacturers and suppliers in China specialized in providing high-quality products at low price. We warmly welcome you to buy or wholesale bulk Supplier Extract Powder for sale here from our factory. For a free sample, contact us now.
Supplier Extract Powder,Supplier Extract ,Supplier Powder Manufacturer in China Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.bodybuildingoil.com